GENTAUR Europe BVBA
Genprice Inc, Logistics
Serbia, 
Macedonia, 
Montenegro, 
Croatia: 
GENTAUR Romania
GENTAUR Greece 
Research at the University of Illinois achieved in the laboratory incredible success: reducing tumor formations in colorectal cancer by 94%! Colon cancer is among the most common, aggressive and lethal forms of cancer.
Impressive result was achieved with peptide lunasin found in soya and any other forms of therapy. Professor Elvira Mejia December revealed that peptide initially used in combination with physiotherapy drug oxaliplatin, which led to a sixfold reduction of metastatic tumors in the liver tissue. Researchers found that lunasina able to penetrate into cancer cells to induce their death and is associated with at least one type of cancer cell receptors, ready to metastasize. This means that the compound is able to recognize not only cancer cells but also to prevent their expansion from other tissues.
On lunasina transcribed almost all beneficial effects of soya, the most studied is its ability to lower cholesterol. It affects the liver enzymes that are responsible for the regulation of the levels of "good" HDL, and "bad" LDL cholesterol levels.
Currently, the research group developed a precise dosage of the medicament to be taken as the normal soybean meal. Their aim is to avoid unnecessary complication through therapy and hospital stays, and to reach the desired concentration of the compound in the blood of patients only by strict diet.
The study was conducted for only 28 days, but their results were impressive. Professor considering encourage producers of fresh milk and yoghurt to include low concentrations of lunasin in their products, thereby preventing cancer before they occur. Market already has flour, enriched with soy peptide, because for years known its anti-inflammatory and cholesterol lowering properties.
Research professor in December Mejia are published in the online Journal Portal cancer treatments in 2013 and enjoy a great deal of attention from around the scientific world.
